Lexicon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that complet…

Biotechnology
US, The Woodlands [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of LXRX's Analysis
CIK: 1062822 CUSIP: 528872302 ISIN: US5288723027 LEI: - UEI: -
Secondary Listings
LXRX has no secondary listings inside our databases.